US5427918A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Fibrin(ogen) derivatives, process for their preparation and their use
Assignee: Siemens Healthcare Diagnostics GmbH Germany
•
Filing: 1993-01-19
•
Granted: 1995-06-27
•
Expires: 2013-01-19
Abstract
Abstract Oxidized derivatives of-fibrin and fibrin or fibrinogen degradation products or partial sequences, process for their preparation and their use as medicaments, for diagnosis or as an affinity agent are described.
Inventors
- 👤 Thomas Stief
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 15:49
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/6456; C12N9/6459; A; A61; A61P; A61P7/00; A61P7/02; C07; C07K; C07K14/00; C07K14/435; C07K14/745; C07K14/75; C12Q; C12Q1/00; C12Q1/56; C12Y; C12Y304/00; C12Y304/21; C12Y304/21069; G; G01; G01N; G01N2333/00; G01N2333/435; G01N2333/745; G01N2333/75
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
113 words
A process for affinity chromatographic purification of a plasminogen activator from a biological fluid comprising the steps of: incubating a solution containing a plasminogen activator with a derivative wherein the plasminogen activator is bound to the derivative and wherein said derivative is a derivative of fibrin, fibrin degradation products or fibrinogen degradation products, or partial sequences thereof, comprising the D-region of fibrinogen, wherein methonine residues in the basic amino acid sequence have been converted to methionine sulfoxide using an oxidant under conditions in which the oxidant is specific for methionine, and wherein essentially no tyrosine residues are iodized; separating the bound plasminogen activator from the biological fluid; and eluting said bound plasminogen activator.
Claim 2
Dependent Claim
113 words
A process for affinity chromatographic purification of a plasminogen activator from a biological fluid comprising the steps of: incubating a solution containing a plasminogen activator with a derivative wherein the plasminogen activator is bound to the derivative and wherein said derivative is a derivative of fibrin, fibrin degradation products or fibrinogen degradation products, or partial sequences thereof, comprising the D-region of fibrinogen, wherein methonine residues in the basic amino acid sequence have been converted to methionine sulfoxide using an oxidant under conditions in which the oxidant is specific for methionine, and wherein essentially no tyrosine residues are iodized; separating the bound plasminogen activator from the biological fluid; and eluting said bound plasminogen activator.
Claim 3
Dependent Claim
73 words
A process for the preparation of a derivative of fibrin, fibrin degradation products or fibrinogen degradation products, or partial sequences thereof, comprising the D-region of fibrinogen, which comprises converting methionine residues in the basic amino acid sequence to methionine sulfoxide using an oxidant under conditions in which the oxidant is specific for methionine and in which essentially no tyrosine residues are iodized, wherein the oxidation is carried out in the presence of octoxynol.
Claim 4
Dependent Claim
73 words
A process for the preparation of a derivative of fibrin, fibrin degradation products or fibrinogen degradation products, or partial sequences thereof, comprising the D-region of fibrinogen, which comprises converting methionine residues in the basic amino acid sequence to methionine sulfoxide using an oxidant under conditions in which the oxidant is specific for methionine and in which essentially no tyrosine residues are iodized, wherein the oxidation is carried out in the presence of octoxynol.
Claim 5
Dependent Claim
123 words
A process for the detection of the presence of t-PA in a biological fluid or the determination of the amount of t-PA in a biological fluid, which comprises: i) adding a derivative of fibrin, fibrin degradation products or fibrinogen degradation products, or partial sequences thereof, comprising the D-region of fibrinogen, wherein methionine residues in the basic amino acid sequence have been converted to methionine sulfoxide using an oxidant under conditions in which the oxidant is specific for methionine, and wherein essentially no tyrosine residues are iodized, to a reaction mixture comprising (a) a sample of said biological fluid, (b) plasminogen, and (c) a chromogenic plasmin substrate; and (ii) detecting the presence or determining the amount of said t-PA based upon the developing color.
Claim 6
Dependent Claim
123 words
A process for the detection of the presence of t-PA in a biological fluid or the determination of the amount of t-PA in a biological fluid, which comprises: i) adding a derivative of fibrin, fibrin degradation products or fibrinogen degradation products, or partial sequences thereof, comprising the D-region of fibrinogen, wherein methionine residues in the basic amino acid sequence have been converted to methionine sulfoxide using an oxidant under conditions in which the oxidant is specific for methionine, and wherein essentially no tyrosine residues are iodized, to a reaction mixture comprising (a) a sample of said biological fluid, (b) plasminogen, and (c) a chromogenic plasmin substrate; and (ii) detecting the presence or determining the amount of said t-PA based upon the developing color.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-06-26 | 1998-12-26 | 1999-06-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-06-26 | 2002-12-26 | 2003-06-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-06-26 | 2006-12-26 | 2007-06-27 | $7700.00 | Window Closed / Lapsed |